Cleared Traditional

K220454 - Vivally System Wearable, Non-Invasive Neuromodulation System and Mobile Application (FDA 510(k) Clearance)

Apr 2023
Decision
410d
Days
Class 2
Risk

K220454 is an FDA 510(k) clearance for the Vivally System Wearable, Non-Invasive Neuromodulation System and Mobile Application. This device is classified as a Stimulator, Peripheral Nerve, Non-implanted, For Urinary Incontinence (Class II - Special Controls, product code NAM).

Submitted by Avation Medical, Inc. (Columbus, US). The FDA issued a Cleared decision on April 3, 2023, 410 days after receiving the submission on February 17, 2022.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5310.

Submission Details

510(k) Number K220454 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 2022
Decision Date April 03, 2023
Days to Decision 410 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code NAM - Stimulator, Peripheral Nerve, Non-implanted, For Urinary Incontinence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5310